Effectiveness of HIV pre-exposure prophylaxis in Peru
Key points
- In this week's PLOS Medicine, Anna Borquez from Imperial College London and an international group of authors developed a mathematical model representing the HIV epidemic among men who have sex with men (MSM) and transwomen in Lima, Peru as a test-case for the effectiveness of HIV pre-exposure prophylaxis (PrEP).
- Funding: This work was principally funded by the Bill & Melinda Gates Foundation.
- Competing Interests: The authors have declared that no competing interests exist.
- Citation: Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, et al.
In this week's PLOS Medicine, Anna Borquez from Imperial College London and an international group of authors developed a mathematical model representing the HIV epidemic among men who have sex with men (MSM) and transwomen in Lima, Peru as a test-case for the effectiveness of HIV pre-exposure prophylaxis (PrEP). The model was used to investigate the population-level impact, cost, and cost-effectiveness of PrEP under a range of different scenarios. The authors found that strategic PrEP intervention could be a cost-effective addition to existing HIV prevention strategies for MSM populations. However, despite being cost-effective, a substantial expenditure would be required to generate significant reductions in incidence of HIV.
###
Funding: This work was principally funded by the Bill & Melinda Gates Foundation. Additional funding: the Medical Research Council UK, The Wellcome Trust, US National Institutes of Health, and The Gladstone Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Gomez GB, Borquez A, Caceres CF, Segura ER, Grant RM, et al. (2012) The Potential Impact of Pre-Exposure Prophylaxis for HIV Prevention among Men Who Have Sex with Men and Transwomen in Lima, Peru: A Mathematical Modelling Study. PLoS Med 9(10): e1001323. doi:10.1371/journal.pmed.1001323
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER (THIS LINK WILL BECOME LIVE WHEN THE EMBARGO LIFTS):
CONTACT:
Annick Borquez
School of Public Health
Imperial College London, United Kingdom
annick.borquez06@imperial.ac.uk
###
Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
Public Library of Science
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →NewsAntibody therapy opens door to potential new treatment for HIV
The development of antiretroviral therapy , a combination of drugs that slows the replication of HIV in the body , has transformed the treatment of this infection. What was once a certain death sentence is now a chronic…
8 May 2016
NewsNew research explains why HIV is not cleared by the immune system
Scientists at the University of North Carolina (UNC) School of Medicine and Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a human (host) protein that weakens the immune response to HIV and…
15 April 2016
NewsGenetic variation shown in patients with severe vascular complications of infection
Major infections such as influenza and bacterial sepsis kill millions of people each year, often resulting fro dangerous complications that impair the body's blood vessels. But the reasons why some patients experience…
